Use of ibuprofen and similar NSAIDs may shorten life of patients with metastatic renal cell carcinoma

Ibuprofen, aspirin, and other non-steroidal anti-inflammatory medications are among the most commonly utilized medications in the United States. Primarily for treating pain, inflammation, and preventing cardiovascular disease, NSAIDs‘ promising anti-cancer properties have been highlighted by a growing body of data in recent years. However, a new study indicated that non-aspirin NSAID use was associated with shorter overall survival in patients with metastatic renal cell carcinoma (mRCC). (Mehr in: Cancer News — ScienceDaily)